Xcout Intel
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. is a biopharmaceutical company located in Waltham, Massachusetts. The company focuses on discovering and developing small-molecule medicines that target RNA to address various serious diseases.
Subscribe to see Arrakis Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Arrakis Therapeutics, Inc. at a glance
Arrakis Therapeutics, Inc. is a biopharmaceuticals company headquartered in United States, founded in 2015. Its most recent funding round raised $15M in April 2019. Xcout tracks 11 named people at Arrakis Therapeutics, Inc., including Mark DeLong (Chief Executive Officer). Xcout recorded 2 job postings from Arrakis Therapeutics, Inc. in the last 90 days.
Arrakis Therapeutics, Inc. leadership
- Mark DeLongChief Executive Officer
- Michael GilmanPresident
- Heather LounsburyChief Operating Officer
- Domi StickensChief Scientific Officer
- James MutambaChief Business Officer
- Eric SchwartzSr. Vice President, Chemistry
5 more named people on record for Arrakis Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Arrakis Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $15M | — | |
| Series B | $75M | 12 named | |
| SEC Form D filing | $13.2M | — | |
| Series A | $38M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Arrakis Therapeutics, Inc.
Xcout recorded 2 job postings from Arrakis Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Arrakis Therapeutics, Inc.'s hiring signals →
Investors
Arrakis Therapeutics, Inc. competitors
A few of Arrakis Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Renasis Bio Ltd. is a stealth-mode private company headquartered in Rehovot, Israel, established in 2025. The firm is developing an AI-driven drug discovery platform focused on RNA-targeting small molecules to advance RNA druggability.
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Actimis Pharmaceuticals, Inc. is a privately held, venture-backed biopharmaceutical company focused on the research and development of small molecule therapeutics for respiratory and inflammatory disorders, such as asthma and rheumatoid arthritis.
CinCor Pharma, Inc. is a U.S.-based drug developer focused on heart and kidney treatments, which was acquired by AstraZeneca. The company was headquartered in Waltham, Massachusetts.
Get Arrakis Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Arrakis Therapeutics, Inc. in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access